Gabor Forgacs, Ph.D., is a visionary director and a theoretical physicist who pivoted to bioengineering and became a successful innovator and entrepreneur. His pioneering work in bioprinting has enabled him to build living structures, leading him to found two companies, Organovo, and Modern Meadow.

The technologies he has developed are cutting-edge and have been applied to drug development and testing and to tissue engineering of biomaterials. Gabor is a George H. Vineyard Professor Emeritus of Biological Physics at the University of Missouri-Columbia and the Chanderna-Shirkey Professor Emeritus of Physics at Clarkson University. He received his training at the Roland Eotvos University in Budapest, Hungary, and has co-authored over 200 scientific articles and 5 books, and has been listed on over 80 issued or published patents.

Gabor has been recognized for his groundbreaking work with numerous awards, including being named one of the "100 most innovative people in business in 2010" by FastCompany. He is a fellow of the American Physical Society and the National Academy of Inventors, and his contributions to the field of bioprinting have revolutionized the way we think about tissue engineering and regenerative medicine.